Giant Lysosomes as a Chemotherapy Resistance Mechanism in Hepatocellular Carcinoma Cells

Area of Science:

• Oncology
• Molecular Biology
• Cell Biology

Background:

• Hepatocellular carcinoma (HCC) poses a significant public health challenge, with multi-drug resistance (MDR) being a primary cause of treatment failure.
• Mechanisms of MDR involve ATP binding cassette (ABC) proteins and drug sequestration within cellular organelles.
• Understanding these mechanisms is crucial for developing more effective HCC therapies.

Purpose of the Study:

• To investigate the role of ABC proteins and cytoplasmic vacuoles in the MDR of hepatocellular carcinoma (HCC) cell lines.
• To confirm the accumulation of sunitinib in cytoplasmic vacuoles within HCC cells.
• To elucidate the relationship between lysosomal vacuoles, P-glycoprotein (PGP) expression, and resistance to sorafenib.

Main Methods:

• Analysis of ABC protein expression in six HCC cell lines.
• Microscopic confirmation of sunitinib accumulation in cytoplasmic vacuoles.
• MTT assays to assess drug resistance and the effect of verapamil on sorafenib treatment.
• Immunohistochemical analysis of PGP expression on cell membranes and lysosomes.

Main Results:

• Sunitinib accumulated in both giant and small cytoplasmic vacuoles of lysosomal origin in HCC cell lines.
• P-glycoprotein (PGP) was the predominant ABC protein, expressed on both cell membranes and lysosomes.
• Cell lines with giant lysosomes exhibited significantly higher resistance to sorafenib compared to those with small lysosomes.
• Verapamil treatment, particularly post-drug incubation, effectively reversed sorafenib resistance.

Conclusions:

• PGP-positive lysosomes play a critical role in drug sequestration and MDR in HCC.
• Lysosomal sequestration of drugs by PGP contributes to treatment failure in HCC.
• Targeting PGP and modulating lysosomal sequestration mechanisms offers a promising strategy for enhancing HCC treatment efficacy.